EBOV002, a Phase 1b, Placebo-controlled, Single-center Randomized Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of INO-4201 as a Booster Vaccination in Healthy Volunteers Who Have Previously Received the VSV-ZEBOV Vaccine

Project: Research project

Project Details

StatusFinished
Effective start/end date11/1/221/19/23

Funding

  • GuardRX ( Award #HR00112200052): $19,670.00